Help reduce screen failures in NASH clinical trials using K18 Biomarkers. Visit us at The Liver Meeting® to learn more.
Event Date: November 9 - 13, 2018
Panels of Biomarkers for
NAFLD, NASH, AH, and DILI Research Featuring K18
Visit us at Booth 601
Diapharma invites you to stop by booth 601 while attending The Liver Meeting® 2018 in San Francisco, CA, November 9 – 13.
Visit Diapharma to discuss K18 assays as prescreening tools and secondary endpoints in NASH clinical trials.
Learn about our panels of mechanistic biomarkers that provide insight into the biological process occurring during liver injury.
- M30 Apoptosense®
- M65 EpiDeath®
- M65® ELISA
Research use only in the U.S. and Canada
Diapharma Group, Inc., 8948 Beckett Rd., West Chester, OH 45069